Heidelberg Pharma AG
XMUN:HPHA
Heidelberg Pharma AG
XMUN:HPHA
Kurs:
2,71
EUR
-0,73%
Marktkap.:
€126,30 Mio.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
KB Home
NYSE:KBH
|
US |
|
Orell Fuessli AG
F:OFH
|
CH |
Gewinn- und Verlustrechnung
Ergebnis-Wasserfall
Heidelberg Pharma AG
Heidelberg Pharma AG
Gewinn- und Verlustrechnung
Heidelberg Pharma AG
Heidelberg Pharma AG
Währung: EUR
| Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatz | |||||||||||||||||||||||||
| Zinsaufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Umsatz |
8
N/A
|
7
-14%
|
9
+29%
|
8
-2%
|
7
-13%
|
6
-16%
|
2
-66%
|
2
-18%
|
2
+20%
|
13
+514%
|
16
+27%
|
19
+13%
|
20
+7%
|
11
-45%
|
9
-14%
|
10
+4%
|
9
-8%
|
10
+5%
|
8
-11%
|
7
-19%
|
7
+0%
|
4
-39%
|
3
-27%
|
1
-52%
|
|
| Bruttogewinn | |||||||||||||||||||||||||
| Umsatzkosten |
(5)
|
(4)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(5)
|
(4)
|
(6)
|
(7)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
|
| Bruttogewinn |
3
N/A
|
2
-28%
|
3
+39%
|
3
-9%
|
2
-24%
|
1
-41%
|
(2)
N/A
|
(3)
-43%
|
(2)
+27%
|
7
N/A
|
9
+44%
|
14
+46%
|
14
+4%
|
7
-52%
|
7
+1%
|
7
-4%
|
7
+9%
|
8
+9%
|
7
-14%
|
5
-26%
|
5
0%
|
4
-28%
|
3
-30%
|
1
-54%
|
|
| Operatives Ergebnis | |||||||||||||||||||||||||
| Operative Kosten |
(15)
|
(18)
|
(20)
|
(21)
|
(22)
|
(23)
|
(22)
|
(23)
|
(24)
|
(26)
|
(27)
|
(32)
|
(31)
|
(34)
|
(29)
|
(28)
|
(27)
|
(22)
|
(27)
|
(29)
|
(27)
|
(28)
|
(30)
|
(47)
|
|
| Vertriebs-, Verwaltungs- und Gemeinkosten |
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
|
| F&E |
(12)
|
(15)
|
(17)
|
(18)
|
0
|
(15)
|
(14)
|
(19)
|
(20)
|
(20)
|
(22)
|
(26)
|
(26)
|
(29)
|
(31)
|
(28)
|
(27)
|
(24)
|
(22)
|
(22)
|
(23)
|
(25)
|
(27)
|
(39)
|
|
| Sonstige operative Kosten |
0
|
1
|
0
|
0
|
(19)
|
(5)
|
(5)
|
(0)
|
(0)
|
(0)
|
1
|
(1)
|
(0)
|
(0)
|
6
|
5
|
6
|
8
|
1
|
(0)
|
3
|
4
|
4
|
(1)
|
|
| Operatives Ergebnis |
(12)
N/A
|
(15)
-31%
|
(17)
-11%
|
(19)
-9%
|
(20)
-8%
|
(22)
-9%
|
(24)
-12%
|
(26)
-7%
|
(26)
-2%
|
(19)
+28%
|
(18)
+6%
|
(18)
-2%
|
(17)
+9%
|
(27)
-61%
|
(23)
+16%
|
(21)
+5%
|
(19)
+9%
|
(14)
+25%
|
(20)
-41%
|
(24)
-17%
|
(22)
+7%
|
(24)
-11%
|
(27)
-11%
|
(46)
-69%
|
|
| Ergebnis vor Steuern | |||||||||||||||||||||||||
| Zinserträge/-aufwendungen |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
4
|
|
| Nicht wiederkehrende Posten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
1
|
|
| Sonstige Erträge gesamt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Vorsteuergewinn |
(12)
N/A
|
(15)
-31%
|
(17)
-11%
|
(18)
-8%
|
(20)
-10%
|
(22)
-10%
|
(25)
-12%
|
(26)
-6%
|
(27)
-4%
|
(20)
+27%
|
(19)
+6%
|
(18)
+5%
|
(17)
+4%
|
(27)
-58%
|
(22)
+18%
|
(20)
+8%
|
(18)
+10%
|
(13)
+28%
|
(19)
-44%
|
(19)
-2%
|
(21)
-8%
|
(23)
-12%
|
(26)
-12%
|
(41)
-58%
|
|
| Nettogewinn | |||||||||||||||||||||||||
| Steueraufwand |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Ergebnis aus fortgeführten Geschäftsbereichen |
(12)
|
(15)
|
(17)
|
(18)
|
(20)
|
(22)
|
(25)
|
(26)
|
(27)
|
(22)
|
(21)
|
(20)
|
(19)
|
(27)
|
(22)
|
(20)
|
(18)
|
(13)
|
(19)
|
(19)
|
(21)
|
(23)
|
(26)
|
(42)
|
|
| Nettogewinn |
(12)
N/A
|
(15)
-31%
|
(17)
-11%
|
(18)
-8%
|
(20)
-10%
|
(22)
-10%
|
(25)
-12%
|
(26)
-6%
|
(27)
-4%
|
(22)
+20%
|
(21)
+5%
|
(20)
+4%
|
(19)
+3%
|
(27)
-42%
|
(22)
+17%
|
(20)
+9%
|
(18)
+10%
|
(13)
+29%
|
(19)
-44%
|
(19)
-3%
|
(21)
-7%
|
(23)
-12%
|
(26)
-12%
|
(42)
-62%
|
|
| Verwässertes EPS |
-0,42
N/A
|
-0,52
-24%
|
-0,53
-2%
|
-0,61
-15%
|
-0,66
-8%
|
-0,71
-8%
|
-0,73
-3%
|
-0,8
-10%
|
-0,78
+3%
|
-0,63
+19%
|
-0,6
+5%
|
-0,53
+12%
|
-0,4
+25%
|
-0,58
-45%
|
-0,48
+17%
|
-0,44
+8%
|
-0,4
+9%
|
-0,28
+30%
|
-0,41
-46%
|
-0,42
-2%
|
-0,45
-7%
|
-0,5
-11%
|
-0,56
-12%
|
-0,91
-62%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Heidelberg Pharma AG listings:
Mehr entdecken
